Guidelines for the prevention and treatment of travelers’ diarrhea: a graded expert panel report
Riddle, Mark S.
Connor, Bradley A.
Dupont, Herbert L.
Hamer, Davidson H.
Tribble, David R.
Ericsson, Charles D.
MetadataShow full item record
Citation (published version)Mark S. Riddle, Bradley A. Connor, Nicholas J. Beeching, Herbert L. DuPont, Davidson H. Hamer, Phyllis Kozarsky, Michael Libman, Robert Steffen, David Taylor, David R. Tribble, Jordi Vila, Philipp Zanger, Charles D. Ericsson; Guidelines for the prevention and treatment of travelers’ diarrhea: a graded expert panel report, Journal of Travel Medicine, Volume 24, Issue suppl_1, 1 April 2017, Pages S63–S80, https://doi.org/10.1093/jtm/tax026
BACKGROUND: Travelers' diarrhea causes significant morbidity including some sequelae, lost travel time and opportunity cost to both travelers and countries receiving travelers. Effective prevention and treatment are needed to reduce these negative impacts. METHODS: This critical appraisal of the literature and expert consensus guideline development effort asked several key questions related to antibiotic and non-antibiotic prophylaxis and treatment, utility of available diagnostics, impact of multi-drug resistant (MDR) colonization associated with travel and travelers' diarrhea, and how our understanding of the gastrointestinal microbiome should influence current practice and future research. Studies related to these key clinical areas were assessed for relevance and quality. Based on this critical appraisal, guidelines were developed and voted on using current standards for clinical guideline development methodology. RESULTS: New definitions for severity of travelers' diarrhea were developed. A total of 20 graded recommendations on the topics of prophylaxis, diagnosis, therapy and follow-up were developed. In addition, three non-graded consensus-based statements were adopted. CONCLUSION: Prevention and treatment of travelers' diarrhea requires action at the provider, traveler and research community levels. Strong evidence supports the effectiveness of antimicrobial therapy in most cases of moderate to severe travelers' diarrhea, while either increasing intake of fluids only or loperamide or bismuth subsalicylate may suffice for most cases of mild diarrhea. Further studies are needed to address knowledge gaps regarding optimal therapies, the individual, community and global health risks of MDR acquisition, manipulation of the microbiome in prevention and treatment and the utility of laboratory testing in returning travelers with persistent diarrhea.
RightsThis work is written by US Government employees and is in the public domain in the US.